abstract |
A pharmaceutical composition is described and in particular a pharmaceutical composition containing (E) -7- [4- (4-fluorophenyl) -6-isopropyl-2 [methyl (methylsulfonyl) amino] pyrimidin-5-yl] - (3R, 5S ) -3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof as the active ingredient and an inorganic salt in which the cation is polyvalent. |